Lotus Eye Hospital And Institute LtdHospitalINE947I01017Standalone₹115.10+1.98 (+1.75%)Jun-26
Valuation
Market Cap₹239.37 Cr
TTM PE1438.75x
Forward PE4316.25x
PEG14.39
Book Value₹28.92
P/B3.98x
TTM EPS₹0.08
Fwd EPS₹0.03
TTM Revenue₹57.26 Cr
TTM PAT₹0.15 Cr
TTM EBITDA₹4.88 Cr
TTM EBIT₹0.31 Cr
Last Qtr PAT₹0.61 Cr
Last Qtr EBITDA₹2.96 Cr
Last Qtr EBIT₹1.32 Cr
Profitability
ROE0.25%
ROCE2.00%
TTM NPM0.26%
TTM EBITDA %8.52%
Curr OPM3.53%
Last OPM-2.27%
Curr NPM
Last NPM
Curr EPS₹0.30
Last EPS₹-0.15
Balance sheet
Equity₹20.80 Cr
Reserve₹39.34 Cr
Total Debt₹15.84 Cr
D/E0.26x
Interest %83.61%
Curr Interest₹0.51 Cr
Price / range
Close₹115.10
vs 52W High-22.02%
vs 52W Low+17.93%
MA50
MA200
Returns
1D+1.75%
1W+1.05%
1M-0.84%
3M-13.37%
6M+5.69%
1Y-6.42%
2Y+53.96%
3Y+33.53%
5Y+145.42%
Diwali-3.64%
Sector peers — Hospital
CompanyCloseMkt CapTTM P/EROE
APOLLOHOSP8944.50₹1.29L Cr81.8716.57%
MAXHEALTH1049.30₹1.02L Cr142.186.68%
MANIPALHOS738.95₹97.20K Cr32.50
FORTIS886.00₹66.89K Cr296.322.29%
ASTERDM755.05₹65.82K Cr224.723.78%
MEDANTA1499.40₹40.31K Cr83.6712.16%
NH1928.50₹39.41K Cr70.7412.20%
KIMS809.85₹34.01K Cr132.3311.02%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue17.06+26.2%13.6113.5513.0413.5253.71
Other Income0.210.480.240.270.191.18
Total Income17.27+26.1%14.0913.7913.3113.7054.89
Interest0.510.330.290.130.120.86
Expenditure-16.25-25.2%-14.56-14.16-13.24-12.98-54.94
PBDT000000
EBITDA2.96+100.0%0.480.660.781.483.38
Depreciation-1.64-1.10-0.98-0.85-0.82-3.75
EBIT1.32+100.0%-0.62-0.32-0.070.66-0.37
PBT1.01+38.4%-0.48-0.380.070.73-0.05
Tax-0.400.160.110.04-0.190.13
Equity20.8020.800020.8020.80
OPM5.85-3.41-2.770.565.33-0.10
Net Profit0.61+13.0%-0.32-0.260.120.540.08
NPM3.53-2.27-1.930.893.940.15
EPS0.30+15.4%-0.15-0.130.060.260.04

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue53.71+8.4%49.56+2.8%48.21+2.5%47.04+20.9%38.91+20.2%32.37
Other Income1.181.301.301.150.890.74
Total Income54.89+7.9%50.86+2.7%49.51+2.7%48.19+21.1%39.80+20.2%33.11
Expenditure-54.94-11.0%-49.49-8.7%-45.51-7.0%-42.54-19.2%-35.69-14.4%-31.20
Interest-0.86-0.36-0.10-0.10-0.13-0.07
PBDT000000
EBITDA3.38-1.7%3.44-47.3%6.53-13.9%7.58+29.6%5.85+63.9%3.57
Depreciation-3.75-3.01-3.73-2.98-2.50-2.33
EBIT-0.37-186.0%0.43-84.6%2.80-39.1%4.60+37.3%3.35+170.2%1.24
PBT-0.05-103.6%1.38-65.6%4.01-29.0%5.65+38.1%4.09+105.5%1.99
Tax0.13-0.64-1.10-1.58-1.11-0.43
Equity20.8020.800000
OPM (%)-0.102.728.0012.0010.006.00
Net Profit0.08-89.2%0.74-74.7%2.92-28.4%4.08+36.9%2.98+89.8%1.57
NPM (%)0.151.456.008.007.005.00
EPS (Rs)0.04-88.9%0.36-74.3%1.40-28.6%1.96+36.1%1.44+182.4%0.51
CEPS0.040.361.401.961.440.51

Consolidated

16 lines · 1 periods
MetricFY25-26
Revenue53.71
Other Income1.18
Total Income54.89
Interest0.86
Expenditure-54.94
PBDT0
EBITDA3.38
Depreciation-3.75
EBIT-0.37
PBT-0.05
Tax0.13
Equity20.80
OPM-0.10
Net Profit0.08
NPM0.15
EPS0.04

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue53.71+8.4%49.56
Other Income1.181.30
Total Income54.89+7.9%50.86
Expenditure-54.94-11.0%-49.49
Interest-0.86-0.36
PBDT00
EBITDA3.38-1.7%3.44
Depreciation-3.75-3.01
EBIT-0.37-186.0%0.43
PBT-0.05-103.6%1.38
Tax0.13-0.64
Equity20.8020.80
OPM (%)-0.102.72
Net Profit0.08-89.2%0.74
NPM (%)0.151.45
EPS (Rs)0.04-88.9%0.36
CEPS0.040.36

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

5
YearTypeAmountEx-Date
2023Final Dividend0.518 Sep 2023
2022Final Dividend0.508 Sep 2022
2021Final Dividend0.508 Sep 2021
2018Final Dividend0.514 Sep 2018
2017Final Dividend0.502 Aug 2017

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers